Rosetta Genomics Ltd. (USA) operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Rosetta Genomics Ltd. (USA) with three other pharmaceutical manufacturers in Middle East: Philadelphia Pharmaceuticals Industry Company PSC of JORDAN (2016 sales of 6.80 million Jordanian Dinars [US$9.59 million] ), Sabaa International Company for Pharmaceutical & Chemical Industries SAE of EGYPT (46.25 million Egyptian Pounds [US$2.93 million] ), and Hayat Pharmaceutical Industries Company PSC which is based in JORDAN (10.54 million Jordanian Dinars [US$14.86 million] ).

Sales Analysis. Rosetta Genomics Ltd. (USA) reported sales of 35.31 million Israel Shekels (US$10.33 million) for the year ending December of 2016. This represents an increase of 9.9% versus 2015, when the company's sales were 32.13 million Israel Shekels. Sales at Rosetta Genomics Ltd. (USA) have increased during each of the previous five years (and since 2011, sales have increased a total of 9,497%).